Trial of Prasinezumab in Early-Stage Parkinson’s Disease
2022 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Trial of Prasinezumab in Early-Stage Parkinson’s Disease
Pagano, G.; Taylor, K. I.; Anzures-Cabrera, J.; Marchesi, M.; Simuni, T.; Marek, K. & Postuma, R. B. et al. (2022)
New England Journal of Medicine, 387(5) pp. 421-432. DOI: https://doi.org/10.1056/NEJMoa2202867
Documents & Media
Details
- Authors
- Pagano, Gennaro; Taylor, Kirsten I.; Anzures-Cabrera, Judith; Marchesi, Maddalena; Simuni, Tanya; Marek, Kenneth; Postuma, Ronald B.; Pavese, Nicola; Stocchi, Fabrizio; Azulay, Jean-Philippe; Bonni, Azad
- Issue Date
- 2022
- Journal
- New England Journal of Medicine
- Organization
- Klinik für Neurologie ; Universitätsmedizin Göttingen
- ISSN
- 0028-4793
- eISSN
- 1533-4406
- Language
- English
